Abstract
Anti-glutamic acid decarboxylase antibody-associated limbic encephalitis (AGADE) is a nonclassic antibody-mediated disease that typically manifests with psychiatric symptoms and seizures in the pediatric population. Glutamic acid decarboxylase (GAD) is highly expressed in the hippocampus and pancreas, which is thought to explain why AGADE tends to also be associated with several endocrine disorders, such as type I diabetes mellitus. The clinical significance of elevated GAD antibodies is still being debated. Nevertheless, if a relevant patient is found to have elevated GAD antibodies, then GABA-A and GABA-B antibodies should also be tested in order to guide with prognosis. IV steroids, IVIG, and plasmapheresis are first-line treatment options. However, immunomodulating agents are often required; rituximab may have the best long-term results. Despite aggressive treatment, unfortunately, most children with AGADE will continue to have symptoms years after diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mustafa K, Yasmin K. Paraneoplastic syndromes affecting the nervous system. In: Swaiman KF, Ashwal S, Ferriero DM, editors. Pediatric neurology: principles & practice, vol. 4th ed. Philadelphia: Mosby; 2007.
Dalmau J, Rosenfeld MR. Autoimmune encephalitis update. Neuro-Oncology. 2014;16(6):771–8.
Mishra N, Rodan LH, Nita DA, Gresa-Arribas N, Kobayashi J, Benseler SM. Anti-glutamic acid decarboxylase antibody associated limbic encephalitis in a child: expanding the spectrum of pediatric inflammatory brain diseases. J Child Neurol. 2014;29(5):677–83.
Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol. 2007;61(6):544–51.
Sloviter RS, Dichter MA, Rachinsky TL, Dean E, Goodman JH, Sollas AL, et al. Basal expression and induction of glutamate decarboxylase and GABA in excitatory granule cells of the rat and monkey hippocampal dentate gyrus. J Comp Neurol. 1996;373(4):593–618.
Saiz A, Blanco Y, Sabater L, Gonzalez F, Bataller L, Casamitjana R, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008;131(10):2553–63.
Christgau S, Aanstoot HJ, Schierbeck H, Begley K, Tullin S, Hejnaes K, et al. Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain. J Cell Biol. 1992;118(2):309–20.
Vincent A, Dale RC. Autoimmune channelopathies and other antibody-associated neurological disorders. In: Dale RC, Vincent A, editors. Inflammatory and autoimmune disorders of the nervous system in children. London: Mac Keith Press; 2010. xvi, 504 p., 8 p. of plates p.
Vianello M, Keir G, Giometto B, Betterle C, Tavolato B, Thompson EJ. Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies. Eur J Neurol. 2005;12(4):294–9.
Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13(3):276–86.
Boronat A, Sabater L, Saiz A, Dalmau J, Graus F. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology. 2011;76(9):795–800.
Korff CM, Parvex P, Cimasoni L, Wilhelm-Bals A, Hampe CS, Schwitzgebel VM, et al. Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition? Arch Neurol. 2011;68(8):1065–8.
Kanter IC, Huttner HB, Staykov D, Biermann T, Struffert T, Kerling F, et al. Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia. 2008;49(5):914.
Haberlandt E, Bast T, Ebner A, Holthausen H, Kluger G, Kravljanac R, et al. Limbic encephalitis in children and adolescents. Arch Dis Child. 2011;96(2):186–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Rudock, R., Helis, J., Mar, S.S. (2017). Anti-glutamic Acid Decarboxylase Limbic Encephalitis. In: Waubant, E., Lotze, T. (eds) Pediatric Demyelinating Diseases of the Central Nervous System and Their Mimics. Springer, Cham. https://doi.org/10.1007/978-3-319-61407-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-61407-6_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61405-2
Online ISBN: 978-3-319-61407-6
eBook Packages: MedicineMedicine (R0)